PAPIVAX BIOTECH INC.
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
Nexuni’s offerings include AI-powered smart parking systems (license-plate recognition, occupancy detection), smart security systems (facial recognition access control, patrol robots), facility management, factory automation, and unmanned store/retail aut
Founded Year
2013
Unified Business No.
54188430
Status
Active
Number of Employees
9
Total Paid-in
Capital
692,870,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
PapiVax Biotech, Inc., founded in 2013 and headquartered in Taipei with a subsidiary in the United States, is a biotech company specializing in nucleic‑acid immunotherapy using proprietary DNA‑plasmid vector and delivery platforms — aiming to become a global leader in treating chronic viral infections and associated cancers.
